Carbamazepine-induced pseudo mycosis fungoides

Annals of Pharmacotherapy

Volumn 37, Issue 10, 2003, Pages 1441-1443

  Gül, Ülker ^a   Kiliç, Arzu ^a   Dursun, Ayşe ^b  

^a Hlth Min Ankara Educ Train Hosp   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

Author keywords

Carbamazepine; Mycosis fungoides; Pseudo mycosis fungoides

Indexed keywords

AMILORIDE PLUS HYDROCHLOROTHIAZIDE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ATENOLOL; CARBAMAZEPINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLUOXETINE; MEXILETINE; PENICILLAMINE; THIORIDAZINE; VALPROIC ACID DERIVATIVE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; CUTANEOUS T CELL LYMPHOMA; DRUG WITHDRAWAL; HISTOPATHOLOGY; HUMAN; MALE; MYCOSIS FUNGOIDES; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; PSEUDOMYCOSIS FUNGOIDES; PUNCH BIOPSY; REMISSION; SEIZURE; SKIN BIOPSY; SYMPTOMATOLOGY; SYSTEMIC DISEASE;

CARBAMAZEPINE; HUMANS; MALE; MIDDLE AGED; MYCOSIS FUNGOIDES; REMISSION INDUCTION; SEIZURES; TIME FACTORS; TREATMENT OUTCOME;

EID: 0141557827     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1D058     Document Type: Article

References (12)

1. Wood SG. Inflammatory diseases that simulate lymphomas: cutaneous pseudolymphomas. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, et al., eds. Dermatology in general medicine. 5th ed. New York: McGraw-Hill, 1999:1882-92.
2. Sacki H, Etoh T, Toda K, Mihm MC Jr. Pseudolymphoma syndrome due to carbamazepine. J Dermatol 1999;26:329-31.
3. Romero AM, Oliva NP, Aragoneses H, Bastida J, Raya C, Lopez AG, et al. Carbamazepine hypersensitivity syndrome mimicking mycosis fungoides. Cutis 2001;67:47-51.
4. Welykyj S, Gradini R, Nakao J, Massa M. Carbamazepine-induced eruption histologically mimicking mycosis fungoides. J Cutan Pathol 1990;17:111-6.
5. Litt ZJ. Drug eruption reference manual. Milennium ed. Cleveland: Parthenon Publishing Group, 2000:76-8.
6. Rijlaarsdam U, Scheffer E, Meijer LM, Willemze R. Cutaneous pseudo-T-cell lymphomas. Cancer 1992;69:717-24.
7. Rijlaarsdam U, Scheffer E, Meijer LM, Kruyswijk RJ, Willemze R. Mycosis fungoides-like lesions associated with phenytoin and carbamazepine therapy. J Am Acad Dermatol 1991;24:216-20.
8. Wolf R, Kahane E, Sandbank M. Mycosis fungoides-like lesions associated with phenytoin therapy. Arch Dermatol 1985;121:1181-2.
9. Gordon KB, Guitart J, Kuzel T, Salard D, Bakouche O, Domer P, et al. Pseudo-mycosis fungoides in a patient taking clonazepam and fluoxetine. J Am Acad Dermatol 1996;34:304-6.
10. Magro CM, Crowson AN. Drugs with antihistaminic properties as a cause of atypical cutaneous lymphoid hyperplasia. J Am Acad Dermatol 1995;32:419-28.
11. Henderson LA, Shamy HK. Atenolol-induced pseudolymphoma. Clin Exp Dermatol 1990;15:119-20.
12. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.